BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4403917)

  • 41. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF; Stratton CD; Hastings SG; Corey RM
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract]   [Full Text] [Related]  

  • 42. Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.
    Lemmer B; Wiethold G; Hellenbrecht D; Bak IJ; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(3):299-313. PubMed ID: 4143918
    [No Abstract]   [Full Text] [Related]  

  • 43. Relationship between beta adrenoceptor occupancy and receptor down-regulation induced by beta antagonists with intrinsic sympathomimetic activity.
    Lima JJ
    J Recept Signal Transduct Res; 1996; 16(5-6):357-72. PubMed ID: 8968966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Action of isoprenaline and -blocking agents on stroke volume regulation.
    Fenyvesi T; Hadházy P
    Eur J Pharmacol; 1973 Apr; 22(1):105-8. PubMed ID: 4145253
    [No Abstract]   [Full Text] [Related]  

  • 45. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 46. Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities.
    Wiethold G; Hellenbrecht D; Lemmer B; Palm D
    Biochem Pharmacol; 1973 Jun; 22(12):1437-49. PubMed ID: 4147326
    [No Abstract]   [Full Text] [Related]  

  • 47. Proceedings: Combined effects of Lb46 resp. practolol and histamine on parameters of respiration and circulation in guinea pigs.
    Kilian U; Dittmann EC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R47. PubMed ID: 4152364
    [No Abstract]   [Full Text] [Related]  

  • 48. Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol.
    Magometschnigg D; Bonelli J; Kaik G
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):429-32. PubMed ID: 41815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of six -adrenoceptive antagonists on airway resistance and heart rate in the guinea-pig.
    Advenier C; Boissier JR; Giudicelli JF
    Br J Pharmacol; 1972 Apr; 44(4):642-50. PubMed ID: 4402819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of beta-adrenergic receptor blocking agents on hypertensive action of noradrenaline injected into the lateral ventricle of rat brain.
    Kleinrok Z; Ksiazek A
    Pol J Pharmacol Pharm; 1977; 29(4):405-9. PubMed ID: 20610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of beta-adrenoceptors in the guinea pig.
    Bertholet A; Milavec M; Waite R
    Postgrad Med J; 1981; 57 Suppl 1():9-17. PubMed ID: 6272256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
    Bonomi L; Perfetti S; Noya E; Bellucci R; Massa F
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Mar; 210(1):1-8. PubMed ID: 35031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
    Kudo Y; Sokabe H; Zehr JE
    J Pharmacobiodyn; 1981 Jul; 4(7):475-82. PubMed ID: 6117611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heart rate after combined vagal and sympathetic blockade with atropine and different beta-receptor blocking agents.
    Fenyvesi T; Káldor A; Sebestyén K
    Int J Clin Pharmacol; 1973 Nov; 8(3):254-7. PubMed ID: 4149237
    [No Abstract]   [Full Text] [Related]  

  • 55. Beta-adrenergic blockade and atrio--ventricular conduction impairment.
    Giudicelli JF; Lhoste F; Boissier JR
    Eur J Pharmacol; 1975 Apr; 31(2):216-25. PubMed ID: 238853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of adrenergic agonists and antagonists on potassium metabolism.
    Lockwood RH; Lum BK
    J Pharmacol Exp Ther; 1974 Apr; 189(1):119-29. PubMed ID: 4823287
    [No Abstract]   [Full Text] [Related]  

  • 57. [Determination in man of the beta blocking properties and the pharmacological half of pargolol (Author's transl)].
    Hugues FC; Julien D; Bors V; Mougeot G; Marche J
    Therapie; 1980; 35(4):475-81. PubMed ID: 6110251
    [No Abstract]   [Full Text] [Related]  

  • 58. [Beta-adrenergic inhibitors (pharmacologic data and deductions for therapeutic application)].
    Salvador M; Marco J; Couderc JJ; Cazard JC
    Cah Med; 1973 Oct; 14(10):877-82. PubMed ID: 4156916
    [No Abstract]   [Full Text] [Related]  

  • 59. [Basis for the use of beta-receptor blockaders in the practice].
    Blankart R
    Schweiz Rundsch Med Prax; 1973 Aug; 62(32):975-8. PubMed ID: 4147247
    [No Abstract]   [Full Text] [Related]  

  • 60. Factors influencing observed beta-adrenergic receptor antagonism in guinea-pig trachea.
    Buckner CK; Birnbaum J; O'Connor M
    Eur J Pharmacol; 1974 May; 26(2):198-203. PubMed ID: 4152883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.